Home Newsfeeds Baird Maintains Outperform on Tapestry, Raises Price Target to $52

Baird Maintains Outperform on Tapestry, Raises Price Target to $52

Baird analyst Mark Altschwager maintains Tapestry (NYSE:TPR) with a Outperform and raises the price target from $45 to $52.

byBenzinga Newsdesk

February 10, 2023

1 minute read

Baird analyst Mark Altschwager maintains Tapestry (NYSE:TPR) with a Outperform and raises the price target from $45 to $52.

A Look Into Haleon Inc’s Price Over Earnings

By Benzinga Insights

October 30, 12:15 PM

In the current market session, Haleon Inc. (NYSE:HLN) share price is at $8.00, after a 2.83% increase. Moreover,…

HLN

Will Fed ‘Chicken Out’ Or ‘Hang Tough’ If Higher Rates Cause Crisis, Asks Peter Schiff: A Majority Say…

By Bhavik Nair

February 27, 1:22 AM

Euro Pacific Capital Chief Economist Peter Schiff conducted a poll on Twitter, asking what the Federal Reserve would do if inflation remains well above the…

BND

Here’s How Much You Would Have Made Owning Take-Two Interactive Stock In The Last 15 Years

By Benzinga Insights

February 13, 11:00 AM

Take-Two Interactive (NASDAQ:TTWO) has outperformed the market over the past 15 years by 9.73% on an annualized basis…

TTWO

Why Unicycive Therapeutics Stock Is Exploding Higher Monday

By Adam Eckert

March 6, 11:20 AM

Unicycive Therapeutics Inc (NASDAQ: UNCY) shares are exploding higher Monday after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb, a phosphate binder that potently controls phosphate with just

UNCY

Baird Maintains Outperform on Tapestry, Raises Price Target to $52

Related Posts

A Look Into Haleon Inc’s Price Over Earnings

Will Fed ‘Chicken Out’ Or ‘Hang Tough’ If Higher Rates Cause Crisis, Asks Peter Schiff: A Majority Say…

Here’s How Much You Would Have Made Owning Take-Two Interactive Stock In The Last 15 Years

Why Unicycive Therapeutics Stock Is Exploding Higher Monday